Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:CHCRNASDAQ:CLOVNYSE:CNCNYSE:MOHNASDAQ:TRUP On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHCRAdvanzeon Solutions$0.00$0.00▼$0.00N/AN/AN/AN/ACLOVClover Health Investments$2.58-0.6%$3.16$1.24▼$4.87$1.32B1.867.04 million shs4.32 million shsCNCCentene$33.28-1.5%$56.42$33.30▼$80.59$16.81B0.445.45 million shs33.74 million shsMOHMolina Healthcare$239.51+0.2%$303.76$236.37▼$365.23$12.95B0.55705,377 shs788,916 shsTRUPTrupanion$52.13+0.3%$48.07$27.40▼$57.90$2.22B1.82614,804 shs630,495 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHCRAdvanzeon Solutions0.00%0.00%0.00%0.00%0.00%CLOVClover Health Investments-0.58%-7.71%-16.94%-22.67%+106.00%CNCCentene-1.55%-37.85%-39.94%-46.44%-50.16%MOHMolina Healthcare+0.45%-17.69%-18.37%-31.03%-19.11%TRUPTrupanion+0.33%-7.31%+5.57%+51.81%+81.01%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCHCRAdvanzeon SolutionsN/AN/AN/AN/AN/AN/AN/AN/ACLOVClover Health Investments2.2582 of 5 stars3.32.00.00.02.01.70.6CNCCentene4.9813 of 5 stars4.23.00.03.72.81.74.4MOHMolina Healthcare4.9918 of 5 stars4.23.00.04.62.92.53.8TRUPTrupanion2.4723 of 5 stars1.41.00.03.01.50.81.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCHCRAdvanzeon Solutions 0.00N/AN/AN/ACLOVClover Health Investments 2.67Moderate Buy$4.8387.70% UpsideCNCCentene 2.41Hold$68.87106.96% UpsideMOHMolina Healthcare 2.44Hold$364.2152.07% UpsideTRUPTrupanion 2.86Moderate Buy$53.803.20% UpsideCurrent Analyst Ratings BreakdownLatest CHCR, CLOV, TRUP, MOH, and CNC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/3/2025TRUPTrupanionPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$52.00 ➝ $62.007/2/2025CNCCenteneBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$65.00 ➝ $52.007/2/2025CNCCenteneBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$65.00 ➝ $45.007/2/2025CNCCenteneCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$90.00 ➝ $65.007/2/2025CNCCenteneJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Neutral$75.00 ➝ $48.007/2/2025CNCCenteneUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Neutral$80.00 ➝ $45.006/9/2025CNCCenteneMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOverweight$70.006/9/2025MOHMolina HealthcareBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$351.00 ➝ $347.006/9/2025MOHMolina HealthcareMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOverweight ➝ Overweight$364.006/2/2025CNCCenteneBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Equal Weight$84.00 ➝ $65.006/2/2025MOHMolina HealthcareBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$362.00 ➝ $351.00(Data available from 7/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCHCRAdvanzeon SolutionsN/AN/AN/AN/AN/AN/ACLOVClover Health Investments$1.37B0.96N/AN/A$0.68 per share3.79CNCCentene$163.07B0.10$9.76 per share3.41$52.49 per share0.63MOHMolina Healthcare$40.65B0.32$26.18 per share9.15$78.60 per share3.05TRUPTrupanion$1.29B1.73$0.29 per share181.35$7.63 per share6.83Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCHCRAdvanzeon SolutionsN/AN/A0.00N/AN/AN/AN/AN/AN/ACLOVClover Health Investments-$43.01M-$0.05N/AN/AN/A-1.69%-7.42%-4.00%8/4/2025 (Estimated)CNCCentene$3.31B$6.714.964.510.402.04%14.56%4.75%7/25/2025 (Estimated)MOHMolina Healthcare$1.18B$20.7111.568.560.802.81%28.38%8.30%7/23/2025 (Estimated)TRUPTrupanion-$9.63M-$0.10N/A248.24N/A-0.32%-1.33%-0.52%8/14/2025 (Estimated)Latest CHCR, CLOV, TRUP, MOH, and CNC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/25/2025Q2 2025CNCCentene$2.07N/AN/AN/A$44.71 billionN/A7/23/2025Q2 2025MOHMolina Healthcare$6.12N/AN/AN/A$10.94 billionN/A5/6/2025Q1 2025CLOVClover Health Investments-$0.07$0.05+$0.12N/A$466.93 million$462.33 million5/1/2025Q1 2025TRUPTrupanion-$0.05-$0.03+$0.02-$0.03$337.81 million$341.98 million4/25/2025Q1 2025CNCCentene$2.52$2.90+$0.38$2.63$43.16 billion$46.62 billion4/23/2025Q1 2025MOHMolina Healthcare$5.96$6.08+$0.12$5.45$10.86 billion$11.15 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCHCRAdvanzeon SolutionsN/AN/AN/AN/AN/ACLOVClover Health InvestmentsN/AN/AN/AN/AN/ACNCCenteneN/AN/AN/AN/AN/AMOHMolina HealthcareN/AN/AN/AN/AN/ATRUPTrupanionN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCHCRAdvanzeon SolutionsN/AN/AN/ACLOVClover Health InvestmentsN/A1.541.54CNCCentene0.651.111.11MOHMolina Healthcare0.871.631.63TRUPTrupanion0.381.701.70Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCHCRAdvanzeon SolutionsN/ACLOVClover Health Investments19.77%CNCCentene93.63%MOHMolina Healthcare98.50%TRUPTrupanionN/AInsider OwnershipCompanyInsider OwnershipCHCRAdvanzeon Solutions16.50%CLOVClover Health Investments24.07%CNCCentene0.36%MOHMolina Healthcare1.10%TRUPTrupanion5.42%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCHCRAdvanzeon Solutions2N/AN/ANot OptionableCLOVClover Health Investments680508.92 million386.42 millionOptionableCNCCentene60,500497.60 million495.81 millionOptionableMOHMolina Healthcare18,00054.20 million53.60 millionOptionableTRUPTrupanion1,13042.78 million40.47 millionOptionableCHCR, CLOV, TRUP, MOH, and CNC HeadlinesRecent News About These CompaniesTrupanion (NASDAQ:TRUP) Price Target Raised to $62.00 at Piper Sandler4 hours ago | americanbankingnews.comTrupanion (NASDAQ:TRUP) Price Target Raised to $62.00July 3 at 9:50 AM | marketbeat.comTrupanion, Inc. (NASDAQ:TRUP) Shares Bought by Palisade Capital Management LPJuly 3 at 9:47 AM | marketbeat.comTrupanion, Inc. (NASDAQ:TRUP) Given Consensus Recommendation of "Moderate Buy" by AnalystsJuly 2 at 4:03 AM | marketbeat.comReport: Nevada sees rise in pet injuries from fireworks; 33 cases reported since 2020July 1 at 2:10 AM | msn.comTrupanion to Host 2025 Annual Investor Day on September 17June 26, 2025 | globenewswire.comSG Americas Securities LLC Buys New Position in Trupanion, Inc. (NASDAQ:TRUP)June 25, 2025 | marketbeat.comCat's meow: Vancouver Island tech named veterinary professional of the yearJune 23, 2025 | nanaimobulletin.comNCat's meow: Saanich vet tech named veterinary professional of the yearJune 21, 2025 | saanichnews.comSTrupanion Announces Winners of the Veterinary Appreciation Dayâ„¢ AwardsJune 18, 2025 | globenewswire.comZacks Industry Outlook Highlights Aflac, Unum, Trupanion, Globe Life and AMERISAFEJune 16, 2025 | finance.yahoo.comInvestors in Trupanion (NASDAQ:TRUP) have seen favorable returns of 92% over the past yearJune 14, 2025 | finance.yahoo.comTrupanion, Inc. (NASDAQ:TRUP) Shares Purchased by GAMMA Investing LLCJune 14, 2025 | marketbeat.com5 Accident & Health Insurance Stocks to Watch as Exposure IncreasesJune 13, 2025 | zacks.comTrupanion (TRUP) Upgraded to Buy: What Does It Mean for the Stock?June 9, 2025 | zacks.comTrupanion, Inc. (NASDAQ:TRUP) Given Consensus Rating of "Moderate Buy" by AnalystsJune 7, 2025 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Boosts Stake in Trupanion, Inc. (NASDAQ:TRUP)June 4, 2025 | marketbeat.comFawwad Qureshi Sells 2,534 Shares of Trupanion, Inc. (NASDAQ:TRUP) StockJune 3, 2025 | insidertrades.comWhat dog owners need to know about foxtail this summerJune 2, 2025 | msn.comTrupanion, Inc. (NASDAQ:TRUP) CFO Fawwad Qureshi Sells 828 SharesMay 30, 2025 | insidertrades.comInsider Sell: Fawwad Qureshi Sells Shares of Trupanion Inc (TRUP)May 29, 2025 | gurufocus.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCHCR, CLOV, TRUP, MOH, and CNC Company DescriptionsAdvanzeon Solutions OTCMKTS:CHCRAdvanzeon Solutions, Inc., through its subsidiary, Pharmacy Value Management Solutions, Inc., administers and operates a sleep apnea program known as SleepMaster Solutions. The company was formerly known as Comprehensive Care Corporation and changed its name to Advanzeon Solutions, Inc. in January 2014. Advanzeon Solutions, Inc. was founded in 1969 and is headquartered in Tampa, Florida. On September 8, 2022, the voluntary petition of Advanzeon Solutions, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on September 7, 2020.Clover Health Investments NASDAQ:CLOV$2.58 -0.02 (-0.58%) Closing price 07/3/2025 03:58 PM EasternExtended Trading$2.58 0.00 (0.00%) As of 07/3/2025 04:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.Centene NYSE:CNC$33.28 -0.51 (-1.49%) Closing price 07/3/2025 03:58 PM EasternExtended Trading$33.28 0.00 (0.00%) As of 07/3/2025 04:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental and speech therapy services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.Molina Healthcare NYSE:MOH$239.51 +0.51 (+0.21%) Closing price 07/3/2025 03:59 PM EasternExtended Trading$239.51 +0.00 (+0.00%) As of 07/3/2025 04:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.Trupanion NASDAQ:TRUP$52.13 +0.17 (+0.33%) Closing price 07/3/2025 01:10 PM EasternExtended Trading$52.68 +0.56 (+1.06%) As of 07/3/2025 04:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Why Occidental's Price Dip Signals a Buying Opportunity Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Rocket Lab: Latest Catalysts Bolster the Bull Case Nike's Stock Just Got an Upgrade: Is a Real Comeback Brewing? Why Hims & Hers Is a Buy Below $35 After Its 16% Pullback Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
